Milan, Italy

Daniela Roncarolo

This inventor holds 8 USPTO granted patents and 1 published patent application, plus 4 CIPO patents and 10 EPO patents. Top assignees: Lofarma S.p.a., Consiglio Nazionale Delle Ricerche. Active years: 2004-2020.

USPTO Granted Patents = 8 

% Patents Active = 100.0


 

Average Co-Inventor Count = 4.1

ph-index = 1

Forward Citations = 2(Granted Patents)


Location History:

  • Rome, IT (2006)
  • Milan, IT (2004 - 2020)

Company Filing History:


Years Active: 2004-2020

Loading Chart...
Loading Chart...
Loading Chart...
8 patents (USPTO):Explore Patents

Title: Daniela Roncarolo: Innovator in Allergen Research

Introduction

Daniela Roncarolo is a prominent inventor based in Milan, Italy. She has made significant contributions to the field of allergen research, holding a total of 8 patents. Her work focuses on developing hypoallergenic variants and methods to reduce allergenicity while preserving immunogenicity.

Latest Patents

Among her latest patents is a method for creating allergoids derived from allergens. This innovative approach involves modifying primary amine groups of lysine and arginine residues in native allergenic materials. The goal is to achieve reduced allergenicity while maintaining the immunogenic response through an IgG-mediated antibody response. Additionally, she has developed hypoallergenic variants of Mal d 1, the major allergen from Malus domestica, which are aimed at treating allergic diseases.

Career Highlights

Throughout her career, Daniela has worked with notable companies such as Lofarma S.p.a. and the National Research Council of Italy. Her expertise in allergen research has positioned her as a key figure in the development of new therapeutic approaches for allergy treatment.

Collaborations

Daniela has collaborated with esteemed colleagues, including Giovanni Mistrello and Stefania Zanotta, who have contributed to her research endeavors.

Conclusion

Daniela Roncarolo's innovative work in allergen research has led to significant advancements in the field, making her a valuable contributor to the scientific community. Her patents reflect her commitment to improving allergy treatments and enhancing patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…